TScan Therapeutics Q3 Revenue Drops After Amgen Collaboration Ends
TScan Therapeutics reported lower Q3 revenue following the end of its collaboration with Amgen.
TScan Therapeutics reported lower Q3 revenue following the end of its collaboration with Amgen.